Last update 05 Dec 2024

Prohibitin targeting peptide 1

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
Adipotide, Prohibitin-TP01, TP01
Target
PHB
Mechanism
PHB modulators(Prohibitin modulators), Apoptosis stimulants
Therapeutic Areas
NeoplasmsEndocrinology and Metabolic DiseaseUrogenital Diseases
Active Indication-
Inactive Indication
Advanced Prostate CarcinomaObesity
Originator Organization
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center
Active Organization-
Inactive Organization
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterAblaris Therapeutics, Inc.
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Prohibitin targeting peptide 1
NCT01262664
/ TerminatedPhase 1IIT
A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity
100 Clinical Results associated with Prohibitin targeting peptide 1
Login to view more data
100 Translational Medicine associated with Prohibitin targeting peptide 1
Login to view more data
100 Patents (Medical) associated with Prohibitin targeting peptide 1
Login to view more data
1
Literatures (Medical) associated with Prohibitin targeting peptide 1
25 Apr 2012Science translational medicineQ1 · MEDICINE
Comment on “A Peptidomimetic Targeting White Fat Causes Weight Loss and Improved Insulin Resistance in Obese Monkeys”
Q1 · MEDICINE
100 Deals associated with Prohibitin targeting peptide 1
Login to view more data

External Link

KEGGWikiATCDrug Bank
-Prohibitin targeting peptide 1--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Prostate CarcinomaPhase 1
US
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center
24 May 2012
ObesityPhase 1
US
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center
24 May 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free